Abstract:Therapeutic Advances in Chronic Disease, Volume 15, Issue , January-December 2024. Growth factors were introduced to increase predictability in periodontal regeneration and have since been widely applied in dentistry. This narrative review article highlights histological and latest findings of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and recombinant human fibroblast growth factor-2 (rhFGF-2) for periodontal regeneration. rhPDGF-BB enhances the proliferation and chemotaxis of periodontal ligament and alveolar bone cells. The optimal dose for rhPDGF-BB, in combination with beta-tricalcium phosphate, is 0.3 mg/ml. It is approved in the United States, Canada, and Taiwan for use in periodontal regeneration and treatment of gingival recession. rhFGF-2 promotes periodontal wound healing through mitogenic and angiogenic effects on mesenchymal cells in the periodontal ligament. It is approved in Japan at an optimal dose of 0.3% for periodontal regeneration in intrabony defects. Both recombinant growth factors show histological evidence of new bone, cementum, and periodontal ligament. Clinical studies demonstrate improved clinical attachment levels and defect resolution for treating intrabony and furcation periodontal defects. Presented clinical cases and consensus reports may serve as a reference for clinicians. rhPDGF-BB and rhFGF-2 are safe and effective biologics that can be applied to improve the outcomes of periodontal regeneration.Plain language summaryUse of growth factors to rebuild lost tissues from gum diseaseGrowth factors are unique proteins introduced to make gum and bone regeneration more predictable in dental treatments. They are now widely used in dentistry. This review focuses on two specific growth factors: recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and recombinant human fibroblast growth factor-2 (rhFGF-2). Key Points: - rhPDGF-BB helps gum and bone cells grow and move to the damaged area. The best dose is 0.3 mg/mL, usually combined with a material called beta-tricalcium phosphate (β-TCP). It's approved in the US, Canada, and Taiwan for regenerating tissue and treating gum recession. - rhFGF-2 aids in healing gum wounds by encouraging cell growth and new blood vessel formation. It's approved in Japan at a dose of 0.3% for treating deep gum and bone defects. Both growth factors have been shown to help form new bone, cementum (the surface layer of the tooth root), and periodontal ligament (the tissue that helps hold the teeth in place). Clinical studies have found that they improve the connection between the tooth and gum and help resolve deep defects. Case studies and expert reports provide valuable guidance for dentists. Both rhPDGF-BB and rhFGF-2 are safe and effective for enhancing gum and bone regeneration in dental treatments.

Periodontal regenerative therapy using recombinant human fibroblast growth factor (rhFGF)-2 in combination with carbonate apatite granules or rhFGF-2 alone: 12-month randomized controlled trial

Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial

Combined Effects of Fibroblast Growth Factor-2 and Carbonate Apatite Granules on Periodontal Healing: An In Vivo and In Vitro Study

A Randomized Clinical Trial Evaluating rh-FGF-2/β-TCP in Periodontal Defects

Predictive factors of periodontal regeneration outcomes using rhFGF‐2: A case–control study

Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid - a randomized controlled clinical trial

Clinical outcomes of guided tissue regeneration with carbonate apatite granules and poly(lactic acid/caprolactone) membrane for the treatment of intrabony defects and mandibular Class II furcation involvements: A 12-month prospective pilot clinical study

Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficiency as adjunctive to the GTR procedure in periodontal intrabony defects

Recombinant Human Derived Growth and Differentiating Factors in treatment of periodontal intrabony defects: Systematic review and network meta‐analysis

Latest update on the use of recombinant growth factors for periodontal regeneration: existing evidence and clinical applications

Effect of Serial Use of Bone Morphogenetic Protein 2 and Fibroblast Growth Factor 2 on Periodontal Tissue Regeneration

Collagen Hydrogel Scaffold and Fibroblast Growth Factor-2 Accelerate Periodontal Healing of Class II Furcation Defects in Dog

Periodontal regeneration using platelet-rich fibrin. Furcation defects: A systematic review with meta-analysis

Autogenous periosteal barrier membranes and bone grafts in the treatment of periodontal intrabony defects of single-rooted teeth: a 12-month reentry randomized controlled clinical trial

Intentional Replantation in Combination with Fibroblast Growth Factor-2 Application and Orthodontic Tooth Extrusion for Periodontal Regeneration in the Treatment of Severe Endodontic-Periodontal Lesions

The effect of titanium-platelet rich fibrin on periodontal intrabony defects: A randomized controlled split-mouth clinical study

Treatment of Periodontal Intrabony Defects Using Bovine Porous Bone Mineral and Guided Tissue Regeneration With/without Platelet-Rich Fibrin: A Randomized Controlled Clinical Trial.

Advantages of Autologous Platelet-Rich Fibrin Membrane on Gingival Crevicular Fluid Growth Factor Levels and Periodontal Healing: A Randomized Split-Mouth Clinical Study

Treating Periodontal Intrabony Defects Using Guided Tissue Regeneration and Bio-Oss® with Platelet-Rich Fibrin: Study Protocol for a Self-Controlled Trial

Regenerative potential of autologous platelet-rich fibrin with and without amnion membrane in the treatment of Grade-II furcation defects: A clinicoradiographic study

Comparative evaluation of autologous platelet-rich fibrin and platelet-rich plasma in the treatment of mandibular degree II furcation defects: a randomized controlled clinical trial